ZA885371B - Tissue factor inhibitor - Google Patents

Tissue factor inhibitor

Info

Publication number
ZA885371B
ZA885371B ZA885371A ZA885371A ZA885371B ZA 885371 B ZA885371 B ZA 885371B ZA 885371 A ZA885371 A ZA 885371A ZA 885371 A ZA885371 A ZA 885371A ZA 885371 B ZA885371 B ZA 885371B
Authority
ZA
South Africa
Prior art keywords
tissue factor
factor inhibitor
inhibitor
tissue
factor
Prior art date
Application number
ZA885371A
Other languages
English (en)
Inventor
George John Broze Jr
John Broze George Jr
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22137642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA885371(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington filed Critical Univ Washington
Publication of ZA885371B publication Critical patent/ZA885371B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA885371A 1987-07-23 1988-07-22 Tissue factor inhibitor ZA885371B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7736687A 1987-07-23 1987-07-23

Publications (1)

Publication Number Publication Date
ZA885371B true ZA885371B (en) 1989-04-26

Family

ID=22137642

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA885370A ZA885370B (en) 1987-07-23 1988-07-22 Dna clone of human tissue factor inhibitor
ZA885371A ZA885371B (en) 1987-07-23 1988-07-22 Tissue factor inhibitor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA885370A ZA885370B (en) 1987-07-23 1988-07-22 Dna clone of human tissue factor inhibitor

Country Status (14)

Country Link
US (3) US6534276B1 (xx)
EP (1) EP0300988A3 (xx)
JP (1) JP2781391B2 (xx)
KR (1) KR900007261B1 (xx)
AU (1) AU604138B2 (xx)
BR (1) BR1100464A (xx)
CA (1) CA1338122C (xx)
DK (1) DK174522B1 (xx)
FI (1) FI97298C (xx)
IL (1) IL87172A (xx)
NO (1) NO174776C (xx)
NZ (1) NZ225534A (xx)
PT (1) PT88075B (xx)
ZA (2) ZA885370B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co ANDC of human tissue factor inhibitor
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
PT98779B (pt) * 1990-08-27 1999-06-30 Monsanto Co Processo para a preparacao de uma composicao anticoagulante contendo inibidor sulfatados e metodos para a sua utilizacao
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
KR100443572B1 (ko) * 2002-05-29 2004-08-09 광양청매실농원영농조합법인 매실 농축액 제조방법
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP2298278B1 (en) * 2002-06-07 2015-11-11 Dyax Corp. Prevention and reduction of blood loss and inflammatory response
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US8828703B2 (en) 2005-12-29 2014-09-09 Dyax Corp. Protease inhibition
WO2007092607A2 (en) * 2006-02-09 2007-08-16 Genetech, Inc. Treatment of hemorrhagic viral infections using a tissue factor inhibitor
US20090075887A1 (en) * 2007-08-21 2009-03-19 Genzyme Corporation Treatment with Kallikrein Inhibitors
JP5580205B2 (ja) * 2007-11-19 2014-08-27 セレラ コーポレーション 肺癌マーカーとその使用
AU2010203712A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
RS62853B1 (sr) 2010-01-06 2022-02-28 Takeda Pharmaceuticals Co Proteini koji vezuju kalikrein plazme
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
CN106459210A (zh) 2014-03-27 2017-02-22 戴埃克斯有限公司 用于治疗糖尿病黄斑性水肿的组合物和方法
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5223427A (en) * 1987-03-31 1993-06-29 The Scripps Research Institute Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
AU1948388A (en) * 1987-06-12 1989-01-04 Mount Sinai School Of Medicine Of The City University Of New York, The Cloning and expression of human tissue factor
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor

Also Published As

Publication number Publication date
CA1338122C (en) 1996-03-05
FI883477A (fi) 1989-01-24
FI97298C (fi) 1996-11-25
US6534276B1 (en) 2003-03-18
PT88075A (pt) 1989-07-31
FI883477A0 (fi) 1988-07-22
US7060805B2 (en) 2006-06-13
DK174522B1 (da) 2003-05-12
US20030166194A1 (en) 2003-09-04
NZ225534A (en) 1991-02-26
EP0300988A3 (en) 1990-04-11
AU1928688A (en) 1989-02-02
ZA885370B (en) 1989-10-25
NO174776C (no) 1994-07-06
EP0300988A2 (en) 1989-01-25
IL87172A0 (en) 1988-12-30
NO174776B (no) 1994-03-28
NO883271L (no) 1989-01-24
JPS6447799A (en) 1989-02-22
DK413588D0 (da) 1988-07-22
NO883271D0 (no) 1988-07-22
AU604138B2 (en) 1990-12-06
US6806360B2 (en) 2004-10-19
DK413588A (da) 1989-01-24
JP2781391B2 (ja) 1998-07-30
PT88075B (pt) 1995-06-30
US20040265981A1 (en) 2004-12-30
KR900007261B1 (en) 1990-10-06
BR1100464A (pt) 2000-02-08
FI97298B (fi) 1996-08-15
KR890001581A (ko) 1989-03-27
IL87172A (en) 1994-12-29

Similar Documents

Publication Publication Date Title
GB2215210B (en) Endoscope
GB8706022D0 (en) Bandages
IL81961A0 (en) Forceps
EP0280397A3 (en) Endoscope
GB2231272B (en) Improved bandage
IL87172A0 (en) Tissue factor inhibitor
EP0282287A3 (en) Deodorizer deodorizer
HU893412D0 (en) Inhibitors of interleucin-1
JPS6429365A (en) Dopamine-beta-hydroxylase inhibitor
AU2027388A (en) Tissue put-up
ZA883851B (en) Dopamine-beta-hydroxylase inhibitors
ZA889709B (en) Dopamine-beta-hydroxylase inhibitors
ZA889667B (en) Dopamine-beta-hydroxylase inhibitors
GB8822157D0 (en) Tissue modification
ZW9087A1 (en) Dopamine-b-hydroxylase inhibitors
GB8805427D0 (en) Scalpel
PT86513A (en) Dopamine-beta-hydroxylase inhibitors
ZA882100B (en) Dopamine-beta-hydroxylase inhibitors
AU102760S (en) Deodorizer
GB8807186D0 (en) Surgical vizors
JPS6410000A (en) Human splenine
EP0371233A3 (en) Technical endoscope
CS862387A1 (en) Smesny inhibitor koroze oceli
CS25787A1 (en) Inhibitor koroze
AU100406S (en) Tissue